MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 88 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 3.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,000 | -32.1% | 6,857 | -7.8% | 0.00% | – |
Q2 2023 | $81,000 | +2600.0% | 7,439 | +1531.4% | 0.00% | – |
Q1 2023 | $3,000 | – | 456 | +714.3% | 0.00% | – |
Q4 2022 | $0 | – | 56 | +7.7% | 0.00% | – |
Q3 2022 | $0 | – | 52 | +10.6% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 47 | -98.0% | 0.00% | – |
Q1 2022 | $21,000 | -77.7% | 2,316 | -70.7% | 0.00% | – |
Q4 2021 | $94,000 | +147.4% | 7,900 | +138.9% | 0.00% | – |
Q3 2021 | $38,000 | -17.4% | 3,307 | +27.6% | 0.00% | – |
Q2 2021 | $46,000 | +21.1% | 2,591 | +6.3% | 0.00% | – |
Q1 2021 | $38,000 | +850.0% | 2,438 | +694.1% | 0.00% | – |
Q4 2020 | $4,000 | +300.0% | 307 | +293.6% | 0.00% | – |
Q3 2020 | $1,000 | – | 78 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |